Your First Month on TRT: What Actually Changes, and What Doesn't Yet

By the end of week four, the things that have moved are mood, energy and sexual interest — and nothing you can see in a mirror. The published time-courses put quality-of-life effects at three to four weeks and sexual interest at about three weeks, while fat mass, lean mass and strength do not begin changing until twelve to sixteen weeks.[1] Month one is real, and it is entirely internal.

What is genuinely in play in the first four weeks

Working from the mapped onset times:[1]

Sexual interest, from around three weeks. This is the earliest reliably reported change, and it moves quickly once it starts — plateauing at six weeks.

Quality of life, within three to four weeks, though maximum benefit takes considerably longer.

Mood, detectable from three to six weeks, building toward a maximum somewhere between eighteen and thirty weeks. So a change in month one is the beginning of that curve, not the whole of it.

Insulin sensitivity, potentially within days — but this is a laboratory observation, not something you feel, and effects on actual glycemic control take three to twelve months.

What has not started

Everything visible. Fat mass, lean body mass and muscle strength change at twelve to sixteen weeks and stabilise between six and twelve months.[1] At week four, none of that has begun.

Red cell production is also still ahead of you: effects on erythropoiesis become evident at three months and peak at nine to twelve.[1] That is the timing that makes the three-month blood panel matter — see the 3-month panel.

What your clinician is doing during month one

The guideline asks for a standardised monitoring plan that evaluates symptoms, adverse effects and compliance, measures serum testosterone and hematocrit, and assesses prostate cancer risk during the first year of therapy.[2]

Two things are worth understanding about that.

Compliance is on the list for a reason. Any topical therapy depends on being applied consistently and correctly. An early result that looks like non-response is sometimes an application problem, and it is one of the first things a good review checks.

The target is mid-normal, not maximal. The guideline suggests aiming at testosterone concentrations in the mid-normal range during treatment.[2] Higher is not the goal, and a man pushing for a number at the top of the range is optimising against a target the evidence does not endorse.

Being honest about what month one can tell you

It cannot tell you whether treatment is working. Three of the four fastest-moving effects — mood, energy, quality of life — are also the three most susceptible to expectation, and the trial evidence on each is modest rather than dramatic. TRAVERSE's depression analysis found improvements in mood and energy that were statistically real and explicitly small.[3]

That is not a reason to discount what you notice. It is a reason to hold it lightly until the objective markers arrive at three months.

Frequently asked questions

I feel nothing at all after four weeks. Is that normal? It is within the published range — mood effects may not become detectable until week six, and considerable individual variation is expected.[1] Worth raising if it persists, and worth confirming your level is actually in the target range.

I feel great in week one. Is that real? Possibly, in part. Very early effects are documented for insulin sensitivity, but the felt effects — mood, energy — are not mapped to week one, and expectation is a genuine contributor. It does not make the experience false; it makes it too early to attribute.

Should I be training harder to make the most of it? Training is worthwhile on its own terms. Just do not read the first month's results as a verdict on the therapy: the strength and lean mass effects are on a twelve-to-sixteen-week clock regardless.[1]

When is my first follow-up blood test? The guideline places structured monitoring — testosterone, hematocrit, prostate risk — within the first year, and the conventional first checkpoint falls at around three months, which is when the erythropoietic effect becomes measurable.[1][2]

What to do with month one

Write down where you started — energy, mood, libido, sleep, and if it matters to you, weight and waist. Month one is too early for a verdict, but it is exactly the right time to have a baseline you did not reconstruct from memory three months later.

Keen connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, treatment is Keen Testosterone Spray Rx — a once-daily topical spray powered by Hypospray® transdermal delivery.

Related reading: how long TRT takes to work and reading your testosterone results.

References

3 sources

1. Saad F, Aversa A, Isidori AM, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol. 2011;165(5):675–685. doi:10.1530/EJE-11-0221 · PMID 21753068
2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 · PMID 29562364
3. Bhasin S, Seidman S, Travison TG, et al. Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy. J Clin Endocrinol Metab. 2024;109(7):1814–1826. doi:10.1210/clinem/dgae026 · PMID 38205962